ALHC Company Profile and Key Details

Alignment Healthcare, Inc. (NASDAQ:ALHC) closed at $19.26 USD, losing -$1.00 (-4.94%) from the previous close of $20.26. The stock is currently mid-range between its 52-week high and low $11.62 and $23.87. With a market capitalization of about $3.93 billion, Alignment Healthcare, Inc. is classified as a mid-cap and shows market-like volatility (beta ~1.20). Key stats such as the average daily volume over the past year has been around 3.41 million shares, trading with heavier-than-usual volume. Headquartered in Orange, CA, Alignment Healthcare, Inc. operates in the Healthcare sector and the Medical - Healthcare Plans industry. Led by CEO John E. Kao, the company employs approximately 1,679 people and listed since March 26, 2021. Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform.

ALHC has shown sold momentum, gaining 6.86% over the past week and 32.83% over the past quarter, though year-to-date performance is up 15.14%. Short-term trend indicators are mixed aligned (SMA20 -2.63%, SMA50 -2.85%, SMA200 19.58%). The stock’s 14-day RSI is 46.32 (neutral), while the ATR of 0.84 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -14.45% below its high and over 75.66% above its low. Average 10-day trading volume of 4.71 million shares is slightly above the 3-month average of 3.25 million, indicating heightened recent market interest.

Alignment Healthcare, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $14.33. This means the shares are trading above this model’s fair value.

Alignment Healthcare, Inc. generated EPS of -$0.12 over the past year. Five-year average earnings growth is -22.95%. The latest quarter delivered EPS of $0.06. The next quarter is forecast at -$0.15. Next year's EPS is expected at $16.46. Analyst sentiment is neutral. Analyst rating data shows there are 5 Strong Buy ratings, 2 Buy ratings, 7 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $30.00 to $13.00. The high target offers 55.76% upside. The low target suggests -32.5% downside. The mean target is $21.07. This offers 9.4% upside. Alignment Healthcare, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended April 30, 2026, missed forecasts by 500.0%. The prior quarter beat by -66.67%. Over the last six quarters, Apple has recorded several small beats. These include -11.11% in February 27, 2025.

Alignment Healthcare, Inc. has 206.73 million shares outstanding. The public float is 172.05 million shares, elevated short interest at 8.43% of float. This equals 16.96 million shares. The short ratio is 4.91 days. Institutional investors hold 97.97% of the float. Insiders own 3.69%. General Atlantic (SPV) GP, LLC holds 67.95 million shares, Warburg Pincus Partners II, L.P. has 19.97 million shares and Warburg Pincus Partners II Holdings, L.P. has 19.97 million shares. Over the past six months, insider transactions show net selling. They sold 24.28 million shares across 45 transactions.